1. MARKETS
  2. SECTOR : PHARMACEUTICALS & BIOTECHNOLOGY
  3. INDUSTRY : MAJOR PHARMACEUTICALS
  4. MERCK & CO INC
Merck & Co Inc XNYS: MRK
Strong Performer, Under Radar
Download real time
83.36 -0.66 (-0.79%)
35.39% Fall from 52W High
9.7M
XNYS Volume

XNYS 11 Jul, 2025 5:30 PM (EDT)

Watchlist

Portfolio

Alert

Share
Acquisition
Merck to acquire Verona Pharma for $10 billion to expand its cardio-pulmonary pipeline & portfolio See details

Merck & Co Inc - MRK - stock price prediction, stock price target, analyst ratings from 26 analysts

Merck & Co Inc has a share price target of US$ 102, revenue growth forecast of 1.2%, and profit growth estimate of 16.6% for FY25, based on top 26 analyst calls.

Forecaster Screeners